PCM Encore »

Aurinia Pharmaceuticals shares owned by PCM Encore

Quarter-by-quarter ownership of Aurinia Pharmaceuticals (AUPH) shares owned by PCM Encore from 13F filings

Historical chart of PCM Encore investment in Aurinia Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Aurinia Pharmaceuticals held by PCM Encore consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aurinia Pharmaceuticals by PCM Encore

Quarter filed Position value Share count Share price at filing
2026-03-31 $399k 27k 14.82

More positions owned by PCM Encore

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Amazon (AMZN)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Russell 2000 Etf (IWM)
Broadcom (AVGO)
Eli Lilly & Co. (LLY)
Meta Platforms Cl A (META)
Exxon Mobil Corporation (XOM)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Berkshire Hathaway Inc Del Cl B New (BRK.B)

View all positions for PCM Encore

Top funds holding Aurinia Pharmaceuticals

Tang Capital Management
BlackRock
NEA Management Company
Arrowstreet Capital, Limited Partnership
State Street Corporation
Two Sigma Investments
Renaissance Technologies
Marshall Wace
D. E. Shaw & Co
Geode Capital Management
Vanguard Group
Two Sigma Advisers
Vanguard Portfolio Management
Nomura Holdings
Jacobs Levy Equity Management

View all funds holding Aurinia Pharmaceuticals